← Patent-cliff monitor small molecule XACIATO CLINDAMYCIN PHOSPHATE
Loss of exclusivity September 2036 latest FDA-listed patent expiry
Company Organon → See this company's full patent-cliff portfolio Drug detail Brand name XACIATO Active ingredient CLINDAMYCIN PHOSPHATE Strength EQ 2% BASE Dosage form GEL Route VAGINAL Modality Small molecule FDA approval December 2021 Marketing status RX
Listed patents Patent Expires Type 11129896 September 2036 use U-3293 12303563 September 2036 product
Regulatory exclusivity Code Expires GAIN December 2029 NP December 2024
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.